Clinical Trials in San Francisco

Showing 12621-12640 of 12,991 trials

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

NCT00109655

The main purpose of this research study is to evaluate the safety and dosing of CG0070.

Carcinoma, Transitional CellBladder Neoplasms

Cell Genesys75 participantsStarted Apr 2005

Phoenix, Arizona, United States • San Francisco, California, United States • Billings, Montana, United States +7 more locations

COMPLETEDPhase 3< 1 mile

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

NCT00000751

To evaluate the effect of anti-HIV immune serum globulin (HIVIG) versus immune globulin (IVIG) administered during pregnancy and to the newborn, in combination with zidovudine (AZT) administered intrapartum and to the newborn, on incidence of HIV infection in infants born to HIV-infected women who received AZT during pregnancy for medical indications. Vertical transmission of HIV from mother to child may occur before, during, or after parturition (via breast-feeding). It is believed that therapy administered both during pregnancy and intrapartum may help prevent vertical transmission. Additionally, adjunctive short-term antiretroviral therapy for the newborn, following the intensive viral exposure presumed to occur at birth, may be necessary.

HIV InfectionsPregnancy

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1,600 participants

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +48 more locations

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

Find Trials by Condition in San Francisco

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

SLV308 for Treatment of Patients With Early Parkinson's Disease

Optimizing Prograf® Therapy in Renal Transplant Patients

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Phase II CT-2103/Carboplatin in Ovarian Cancer

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Attain StarFix™ Model 4195 Left Ventricular Lead

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

Long-Term Follow-Up Study of Psoriasis Patients

Chemoprevention of Oral Premalignant Lesions